Top Tech Startups in San Francisco Bay Area in 2024

Flyward is a technology company originating from Silicon Valley in the United States, dedicated to pushing the boundaries of innovation in the field of fully autonomous eVTOL/flying cars. Our team is composed of vibrant individuals who are passionate about technology and share a common vision to create breakthrough solutions. Leveraging advanced artificial intelligence and autonomous navigation technologies, we aspire to turn the concept of urban air mobility into reality, ushering in a new era where convenient and efficient flight becomes accessible to every household. Join us and contribute to groundbreaking advancements in this field. If you are passionate about pushing the boundaries of innovation, we invite you to become a member of our dynamic team!

Lumo is a smart irrigation system for vineyards that helps growers save water, reduce costs and improve grape quality. With Lumo, growers gain unprecedented visibility and control, enabling them to irrigate more precisely and efficiently. Since Lumo is cloud-managed, it can be controlled and monitored from anywhere, reducing the number of required site visits, time spent on-site, and thereby reducing labor costs. To learn more about Lumo, visit Lumo.Ag

Upthread provides you with an easy to use platform that helps companies get their sales targets to sign on the bottom line.

IonPath is a Stanford University spin-out with a vision to transform clinical pathology and tumor imaging, a $10B+ market, with the company's novel, highly multi-parametric imaging technology, Multiplexed Ion Beam Imaging (MIBI). IonPath's MIBI is a step-change improvement over the current leading tumor imaging method, immunohistochemistry (IHC). MIBI enables researchers, pathologists, and clinicians to quantitatively analyze and visually display the complex interactions among cancer tumor cells, proteins, antibodies, T-cells, and other relevant features on cells' surfaces and interiors. Understanding these biological players and their interactions should substantially improve cancer research and drug discovery, produce novel diagnostics, and transform the study of disease mechanisms such as cancer ("pathology"). IonPath will develop and commercialize services, instruments, reagents, and ultimately diagnostic tests based on MIBI technology.

Etleap ETL removes the headaches experienced building data pipelines. A cloud-native platform that seamlessly integrates with AWS infrastructure, Etleap ETL consolidates data without the need for coding. Our purpose is to unlock the power of data and enable analytics teams to be more productive by removing the need for internal IT resources or knowledge of complex scripting languages, reducing the time spent on typical ETL projects from weeks to hours. With rich features like wrangling, modeling, and VPC deployment, Etleap arms data teams with the ability to parse, structure, de-identify, clean, and secure their data effortlessly while modeling data with SQL for performance and analytics readiness - all in just a few clicks.

DeFi enables anyone to perform jobs previously reserved to banks like market making or lending. This unlocks incredible yield opportunities for investors. However, investing in DeFi is incredibly complex. We are on a mission to make DeFi accessible to all. Our multichain trading platform makes it easy for anyone to put their assets to work on DeFi. We are transitioning web2 to web3.